IVI RMA North America Rebranded as Everleap Fertility
The national fertility provider has unified under a new name as it reports new findings on the scale of infertility in the U.S.
Updated on Oct. 13, 2026 in Pregnancy
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
IVI RMA North America has rebranded as Everleap Fertility to unify its network of over 65 clinics and 26 IVF laboratories. The announcement accompanied the release of the inaugural IVI Institute Fertility Barometer, which tracks the experiences of women navigating family planning across the country.
Why it matters
The organization hopes the rebranding will better reflect recent advancements in fertility science and standard of care. These insights into fertility trends provide a clearer picture of the challenges many families face when trying to start a family today.
Everleap Fertility operates more than 65 clinics and 26 laboratories in the U.S., staffed by over 200 physicians and embryologists. The organization's recent survey found that 63% of women who received IVF treatment successfully had a baby.
The players
Everleap Fertility
A national fertility services provider headquartered in Basking Ridge, New Jersey, that operates over 65 clinics.
IVI Institute
The Spain-based parent organization that oversees international research and clinical fertility standards.
Conceivable Life Sciences
A fertility technology developer partnering with the organization to provide automated laboratory systems.
The details
The rebrand unites regional practices under one brand to streamline the delivery of fertility services. The company utilizes a network of nine practices supported by a proprietary electronic medical records platform that features an AI-powered assistant. Future plans include the integration of fully automated embryology technology developed by Conceivable Life Sciences to further modernize their laboratory processes.
Timeline
October 13, 2026: The rebrand and survey results were announced.
2027: The organization plans to launch its first fully automated embryology lab.
The Home Front
This move reflects a broader trend of large fertility networks consolidating under unified brands to standardize care across regions. It follows the publication of the inaugural IVI Institute Fertility Barometer, which quantifies the 21% of U.S. women who have faced infertility struggles.
If you are beginning your family planning journey, consider researching providers that offer integrated electronic medical records and modern laboratory technology. Families should verify if their current clinic remains in-network during this transition to the new brand.
The takeaway
Understanding the prevalence of infertility, which has affected 21% of U.S. women, is the first step toward seeking appropriate medical consultation. If you are struggling with fertility, note that over 75% of women in your position seek help from a doctor.
Further reading
For more information on family planning and reproductive health, visit our Pregnancy section.
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
